User profiles for Mauro Turrini

Mauro Turrini

Spanish National Research Council (CSIC) · Instituto de Políticas y Bienes Públicos (RoR …
Verified email at cchs.csic.es
Cited by 461

[HTML][HTML] Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre …

…, P Tosi, F Lanza, M Massaia, M Turrini… - The Lancet …, 2020 - thelancet.com
Background Several small studies on patients with COVID-19 and haematological
malignancies are available showing a high mortality in this population. The Italian Hematology …

[HTML][HTML] Beyond clinical utility: the multiple values of DTC genetics

M Turrini, B Prainsack - Applied & translational genomics, 2016 - Elsevier
One point of consensus in the otherwise very controversial discussion about the benefits and
dangers of DTC genetics in the health domain is the lack of substantial clinical utility. At the …

A genealogy of “healthism”

M Turrini - Eä-Journal of Medical Humanities & Social Studies of …, 2015 - hal.science
Healthism is a sociological concept that has circulated widely outside of academia, while is it
rather neglected by social sciences. This article intends to propose its genealogy in order to …

Care in practice. On normativity, concepts, and boundaries

A Mol, I Moser, EM Piras, M Turrini, J Pols, A Zanutto - 2011 - digital.csic.es
In recent years many STS scholars have dealt with care practices in different fields. Starting
from Care in Practice. On Tinkering in Clinics, Homes and Farms [Transcript-Verlag, …

Assessing energy expenditure in cancer patients: a pilot validation of a new wearable device

E Cereda, M Turrini, D Ciapanna… - Journal of Parenteral …, 2007 - Wiley Online Library
Background: Nutrition problems are common in cancer patients and are frequently due to
metabolic derangements. Thus, accurately assessing energy expenditure (EE) is important in …

Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature

L Marbello, F Ricci, AM Nosari, M Turrini, G Nador… - Leukemia research, 2008 - Elsevier
Hyperleukocytic acute myeloid leukaemia is considered to have a poor prognosis due to
high early death rate secondary to leukostasis. Supportive treatments do not seem to have …

COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies

…, M Cavo, C Fava, M Turrini… - British Journal of …, 2021 - Wiley Online Library
COVID‐19 is associated with high mortality in patients with haematological malignancies (HM)
and rate of seroconversion is unknown. The ITA‐HEMA‐COV project (NCT04352556) …

The evolution of personalized healthcare and the pivotal role of European regions in its implementation

…, V Osmani, PG Cormio, A Frosini, M Turrini… - Personalized …, 2021 - Future Medicine
Personalized medicine (PM) moves at the same pace of data and technology and calls for
important changes in healthcare. New players are participating, providing impulse to PM. We …

Soggettività intermittenti: un'inchiesta sulla scomposizione del lavoro nell'ambito delle industrie creative

F Chicchi, M Savioli, M Turrini - … del lavoro nell'ambito delle industrie …, 2014 - torrossa.com
La storia sociale del lavoro durante tutto il secolo breve è per lo più sovrapponibile con la
produzione, nelle sue diverse e composite tonalità, di una forma specifica di soggettività. Il …

Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: the GIMEMA EMATO‐0321 study

…, M Bocchia, A Visentin, M Turrini… - British Journal of …, 2022 - Wiley Online Library
COVID‐19 continues to be a relevant issue among patients with haematological malignancies
(HM). Vaccines are frequently not effective in subjects on active treatment. In this …